COMBINATION OF A PD-1 ANTAGONIST AND ERIBULIN FOR TREATING CANCER

• 收藏
• 分享

专利权人:

MERCK SHARP & DOHME CORP.;EISAI R&D MANAGEMENT CO., LTD.

发明人:

MATSUI, Junji,AKTAN, Gursel,KARANTZA, Vassiliki,YUAN, RuiRong,FUNAHASHI, Yasuhiro,BERRAK, Erhan

申请号：

SG11201706872S

公开号：

SG11201706872SA

申请日:

2016.03.03

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and eribulin or a pharmaceutically acceptable salt thereof, and the use of the combination therapies for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/